175 related articles for article (PubMed ID: 21222549)
1. Current perspectives on pharmacotherapy of Alzheimer's disease.
Chopra K; Misra S; Kuhad A
Expert Opin Pharmacother; 2011 Feb; 12(3):335-50. PubMed ID: 21222549
[TBL] [Abstract][Full Text] [Related]
2. Neurobiological aspects of Alzheimer's disease.
Chopra K; Misra S; Kuhad A
Expert Opin Ther Targets; 2011 May; 15(5):535-55. PubMed ID: 21314231
[TBL] [Abstract][Full Text] [Related]
3. Novel disease-modifying therapies for Alzheimer's disease.
Jiang T; Yu JT; Tan L
J Alzheimers Dis; 2012; 31(3):475-92. PubMed ID: 22669013
[TBL] [Abstract][Full Text] [Related]
4. Novel insights for the treatment of Alzheimer's disease.
Kurz A; Perneczky R
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):373-9. PubMed ID: 20655969
[TBL] [Abstract][Full Text] [Related]
5. Current therapeutic strategy in Alzheimer's disease.
Singh S; Kushwah AS; Singh R; Farswan M; Kaur R
Eur Rev Med Pharmacol Sci; 2012 Nov; 16(12):1651-64. PubMed ID: 23161037
[TBL] [Abstract][Full Text] [Related]
6. [Recent progress in the development of disease-modifying therapies for Alzheimer's disease].
Abe K
Nihon Shinkei Seishin Yakurigaku Zasshi; 2010 Feb; 30(1):1-8. PubMed ID: 20297736
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological treatment for Alzheimer's disease: current approaches and future strategies.
Fan LY; Chiu MJ
Acta Neurol Taiwan; 2010 Dec; 19(4):228-45. PubMed ID: 21213151
[TBL] [Abstract][Full Text] [Related]
8. Small-molecule inhibitors/modulators of amyloid-β peptide aggregation and toxicity for the treatment of Alzheimer's disease: a patent review (2010 - 2012).
Belluti F; Rampa A; Gobbi S; Bisi A
Expert Opin Ther Pat; 2013 May; 23(5):581-96. PubMed ID: 23425062
[TBL] [Abstract][Full Text] [Related]
9. Strategies, development, and pitfalls of therapeutic options for Alzheimer's disease.
Haas C
J Alzheimers Dis; 2012; 28(2):241-81. PubMed ID: 21987594
[TBL] [Abstract][Full Text] [Related]
10. Challenges in the treatment of Alzheimer's disease: recent progress and treatment strategies of pharmaceuticals targeting notable pathological factors.
Kuo YC; Rajesh R
Expert Rev Neurother; 2019 Jul; 19(7):623-652. PubMed ID: 31109210
[No Abstract] [Full Text] [Related]
11. Beyond amyloid: the future of therapeutics for Alzheimer's disease.
Lane RF; Shineman DW; Steele JW; Lee LB; Fillit HM
Adv Pharmacol; 2012; 64():213-71. PubMed ID: 22840749
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease: strategies for disease modification.
Citron M
Nat Rev Drug Discov; 2010 May; 9(5):387-98. PubMed ID: 20431570
[TBL] [Abstract][Full Text] [Related]
13. Drug development in dementia.
Cunningham EL; Passmore AP
Maturitas; 2013 Nov; 76(3):260-6. PubMed ID: 23707728
[TBL] [Abstract][Full Text] [Related]
14. Advances in the therapy of Alzheimer's disease: targeting amyloid beta and tau and perspectives for the future.
Hampel H; Schneider LS; Giacobini E; Kivipelto M; Sindi S; Dubois B; Broich K; Nisticò R; Aisen PS; Lista S
Expert Rev Neurother; 2015 Jan; 15(1):83-105. PubMed ID: 25537424
[TBL] [Abstract][Full Text] [Related]
15. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
Clausen A; Xu X; Bi X; Baudry M
J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
[TBL] [Abstract][Full Text] [Related]
16. Emerging amyloid and tau targeting treatments for Alzheimer's disease.
Khan A; Corbett A; Ballard C
Expert Rev Neurother; 2017 Jul; 17(7):697-711. PubMed ID: 28490214
[TBL] [Abstract][Full Text] [Related]
17. Therapeutics of Alzheimer's disease: Past, present and future.
Anand R; Gill KD; Mahdi AA
Neuropharmacology; 2014 Jan; 76 Pt A():27-50. PubMed ID: 23891641
[TBL] [Abstract][Full Text] [Related]
18. [Therapy of Alzheimer disease].
Kovács T
Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of Alzheimer's disease].
Bombois S; Lebert F; Vellas B; Pasquier F
Rev Prat; 2005 Nov; 55(17):1913-9. PubMed ID: 16396232
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy for Alzheimer's disease.
Wang W; Fan L; Xu D; Wen Z; Yu R; Ma Q
Acta Biochim Biophys Sin (Shanghai); 2012 Oct; 44(10):807-14. PubMed ID: 22899646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
